Recent Finacing
Recent Raise
Aurum Biosciences is a Scotland-based spinout developing ABL-101, an oxygen carrier used as a therapeutic and 19F MRI contrast agent targeting stroke, spinal‑cord injury, radiotherapy‑resistant tumors, and post‑cardiac‑arrest organ damage.
